{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,6,6]],"date-time":"2022-06-06T16:41:06Z","timestamp":1654533666604},"reference-count":5,"publisher":"EDITORA SCIENTIFIC","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rev. Bras. Psiquiatr."],"published-print":{"date-parts":[[2011,6]]},"DOI":"10.1590\/s1516-44462011000200003","type":"journal-article","created":{"date-parts":[[2011,8,5]],"date-time":"2011-08-05T13:02:32Z","timestamp":1312549352000},"page":"113-114","source":"Crossref","is-referenced-by-count":0,"title":["O controle dos medicamentos anor\u00e9ticos: mais um conto para as calendas gregas?"],"prefix":"10.47626","volume":"33","author":[{"given":"E.A","family":"Carlini","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"27448","reference":[{"key":"ref1","series-title":"Stimulants in schedule IV of the 1971 Convention used as anorectics","first-page":"26","year":"2005"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1590\/S1984-82502010000200017","article-title":"Prescription of anorectic and benzodiazepine drugs through notification B prescription in Natal, RG Norte: Brazil","volume":"46","author":"Nappo AS","year":"2010","journal-title":"Braz J Pharm Sci"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1590\/S0047-20852009000200005","article-title":"Fluoxetina: ind\u00edcios do uso inadequado","volume":"58","author":"Carlini EA","year":"2009","journal-title":"J Bras Psiquiatr."},{"key":"ref4","first-page":"417","article-title":"Consumo de anorexigenos tipo-anfetamina (dietilpropiona, fenproporex, mazindol) e fenfluramina no Brasil: preju\u00edzo ou benef\u00edcio para a sa\u00fade?","volume":"41","author":"Nappo SA","year":"1992","journal-title":"J Bras Psiquiatr","ISSN":"http:\/\/id.crossref.org\/issn\/0047-2085","issn-type":"print"},{"key":"ref5","article-title":"Regulatory matters. Sibutramine: suspension of marketing authorizations recommended in the European Union e Market withdrawal due to risk of serious cardiovascular events","volume":"6","year":"2010","journal-title":"WHO Pharmaceuticals Newsletter"}],"container-title":["Revista Brasileira de Psiquiatria"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/pdf\/rbp\/v33n2\/a03v33n2.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,6]],"date-time":"2022-06-06T16:12:38Z","timestamp":1654531958000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S1516-44462011000200003&lng=pt&tlng=pt"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,6]]},"references-count":5,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,6]]}},"alternative-id":["S1516-44462011000200003"],"URL":"https:\/\/doi.org\/10.1590\/s1516-44462011000200003","relation":{},"ISSN":["1516-4446"],"issn-type":[{"value":"1516-4446","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,6]]}}}